公开(公告)号：US20240310387A1

公开(公告)日：2024-09-19

申请号：US18575507

申请日：2022-06-28

Applicant: BERYSOL GMBH

Inventor： Lutz SCHOMBURG

IPC: G01N33/68 ,  G01N33/53

CPC classification number: G01N33/6893 ,  G01N33/5308 ,  G01N2800/50

Abstract: Instant invention discloses a method for evaluating the risk of selenium (Se) deficiency in a subject by determining both the amount of selenium or selenoprotein P and the amount of antibodies against selenoprotein P, estimating or calculating a risk index score for the Se deficiency of said subject using the obtained values, and the use of the method of the invention or of the risk index score obtained according to the invention in the monitoring of Se supplementation, especially in subjects suffering from a disease related to a selenium deficit.

公开(公告)号：US20220082573A1

公开(公告)日：2022-03-17

申请号：US17418189

申请日：2019-12-19

Applicant: berYsol GmbH

Inventor： Lutz Schomburg ,  Eike Christian Kuehn

IPC: G01N33/68

Abstract: The present invention refers to an immunoassay for determining the amount of selenium binding protein 1 (SELENBP1) in the body liquid of an individual suspected of suffering from peracute tissue damage and detecting pathologically elevated levels of SELENBP1, the diagnostic use of this immunoassay and a kit for the performance of a diagnostic assay comprising an antibody against SELENBP1.